Integrative In Silico Design and In Vivo Validation of a CCHFV T- cell Epitope Mitigating Hepatic Viral Load

Abstract Crimean–Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen responsible for severe hemorrhagic disease in humans, frequently associated with systemic inflammation and significant hepatic involvement. The S genomic segment encodes the nucleoprotein (NP), a highly constrained component of the viral replication machinery. While the evolutionary dynamics of CCHFV have been studied, the translation of genomic variability into immunopathogenic mechanisms and rational vaccine targets remains incompletely characterized. In this study, we employed a multi-tiered in silico approach, combining comparative genomics of 577 global S segment sequences with comprehensive epitope mapping and molecular docking. Genomic analysis, including Shannon entropy, principal component analysis (PCA), and network modeling, revealed discrete lineage clusters and strictly conserved structural domains. Building upon these conserved regions, immunoinformatics profiling identified 3 highly conserved MHC-I and 4 MHC-II epitopes. Crucially, the lead T-cell epitope (ETFPTVSQF) was identified. Molecular docking analysis against human Toll-like receptor 4 (TLR4) using GalaxyPepDock demonstrated robust binding affinities and high structural compatibility, yielding TM-scores up to 0.780 and interaction similarity scores up to -15.0. Furthermore, C-IMMSIM immunological simulations predicted strong, sustained memory B- and T-cell responses, characterized by robust IFN-γ production and high immunoglobulin titers, ensuring efficient viral clearance profiles. Crucially, in vivo validation in mouse models demonstrated that the adjuvanted ETFPTVSQF peptide drastically reduced hepatic viral loads compared to PBS controls (*** P < 0.001), confirming its protective efficacy against liver injury. Collectively, these findings provide a global genomic perspective on CCHFV S segment diversity and propose structurally conserved, immunogenic candidates that could guide the development of targeted diagnostics and recombinant vaccines mitigating hepatic and systemic injury.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-10948331/v1
Primary Topic
vaccines and immunoinformatics approaches
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative In Silico Design and In Vivo Validation of a CCHFV T- cell Epitope Mitigating Hepatic Viral Load

Amirhossein Amini, Maryam Akrami, Meisam Akrami
Research Square
vaccines and immunoinformatics approaches
preprint

Integrative In Silico Design and In Vivo Validation of a CCHFV T- cell Epitope Mitigating Hepatic Viral Load

Amirhossein Amini, Maryam Akrami, Meisam Akrami
preprint en

Abstract

Abstract Crimean–Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen responsible for severe hemorrhagic disease in humans, frequently associated with systemic inflammation and significant hepatic involvement. The S genomic segment encodes the nucleoprotein (NP), a highly constrained component of the viral replication machinery. While the evolutionary dynamics of CCHFV have been studied, the translation of genomic variability into immunopathogenic mechanisms and rational vaccine targets remains incompletely characterized. In this study, we employed a multi-tiered in silico approach, combining comparative genomics of 577 global S segment sequences with comprehensive epitope mapping and molecular docking. Genomic analysis, including Shannon entropy, principal component analysis (PCA), and network modeling, revealed discrete lineage clusters and strictly conserved structural domains. Building upon these conserved regions, immunoinformatics profiling identified 3 highly conserved MHC-I and 4 MHC-II epitopes. Crucially, the lead T-cell epitope (ETFPTVSQF) was identified. Molecular docking analysis against human Toll-like receptor 4 (TLR4) using GalaxyPepDock demonstrated robust binding affinities and high structural compatibility, yielding TM-scores up to 0.780 and interaction similarity scores up to -15.0. Furthermore, C-IMMSIM immunological simulations predicted strong, sustained memory B- and T-cell responses, characterized by robust IFN-γ production and high immunoglobulin titers, ensuring efficient viral clearance profiles. Crucially, in vivo validation in mouse models demonstrated that the adjuvanted ETFPTVSQF peptide drastically reduced hepatic viral loads compared to PBS controls (*** P < 0.001), confirming its protective efficacy against liver injury. Collectively, these findings provide a global genomic perspective on CCHFV S segment diversity and propose structurally conserved, immunogenic candidates that could guide the development of targeted diagnostics and recombinant vaccines mitigating hepatic and systemic injury.

Research Square
Islamic Azad University, Tehran (IR), Islamic Azad University Medical Branch of Tehran (IR)
Good health and well-being
vaccines and immunoinformatics approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon